TimesSquare Capital Management’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-774,200
Closed -$15.4M 224
2018
Q4
$15.4M Sell
774,200
-560,938
-42% -$13M 0.13% 189
2018
Q3
$37.9M Sell
1,335,138
-187,112
-12% -$4.46M 0.25% 152
2018
Q2
$32M Sell
1,522,250
-30,800
-2% -$583K 0.21% 169
2018
Q1
$22.1M Sell
1,553,050
-31,900
-2% -$457K 0.15% 191
2017
Q4
$19.5M Sell
1,584,950
-7,350
-0.5% -$104K 0.13% 202
2017
Q3
$28.3M Buy
1,592,300
+86,300
+6% +$1.78M 0.19% 175
2017
Q2
$38.2M Buy
1,506,000
+196,000
+15% +$4.71M 0.25% 156
2017
Q1
$29.2M Sell
1,310,000
-58,200
-4% -$1.12M 0.19% 191
2016
Q4
$20.2M Buy
1,368,200
+280,000
+26% +$5.52M 0.14% 209
2016
Q3
$26.8M Sell
1,088,200
-11,855
-1% -$277K 0.17% 193
2016
Q2
$21.1M Sell
1,100,055
-92,700
-8% -$1.27M 0.14% 199
2016
Q1
$12.6M Buy
1,192,755
+207,755
+21% +$2.15M 0.08% 210
2015
Q4
$11.9M Buy
985,000
+162,000
+20% +$2.39M 0.08% 215
2015
Q3
$13.1M Buy
823,000
+622,500
+310% +$12.1M 0.08% 216
2015
Q2
$3.91M Buy
+200,500
New +$3.74M 0.02% 242

Other funds holding EVH

TimesSquare Capital Management's EVH Position: Q1 2019 in Review

TimesSquare Capital Management sold out of Evolent Health (EVH) in Q1 2019, closing a stake of 774,200 shares — an estimated $15.4M sold.

TimesSquare Capital Management first reported a position in EVH in Q2 2015 and held it in 15 quarters. The position peaked at $38.2M in Q2 2017. 192 funds tracked by Wall St. Rank hold EVH as of Q1 2019.

  • TimesSquare Capital Management reported no remaining Evolent Health position as of Q1 2019 after selling out during the quarter.
  • TimesSquare Capital Management sold 774,200 Evolent Health shares in Q1 2019, an estimated $15.4M.
  • TimesSquare Capital Management first reported a position in Evolent Health in Q2 2015 and held it in 15 quarters.
  • TimesSquare Capital Management's Evolent Health position peaked at $38.2M in Q2 2017.
  • 192 funds tracked by Wall St. Rank held Evolent Health as of Q1 2019.

Based on TimesSquare Capital Management's 13F filing for Q1 2019, filed 10 May 2019.